Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137280 · ClinicalTrials.gov registry record · NA
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
A NA study of Schizophrenia and Weight Gain, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,067
- Enrollment target
- 8
- Study locations
NCT00137280: Completed NA study of Schizophrenia and Weight Gain, sponsored by VA Office of Research and Development.
NCT00137280 is a NA study of Schizophrenia and Weight Gain that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,067 participants, above the 216-participant average among 315 other Schizophrenia trials with a reported enrollment target (394% higher). The trial reports 8 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00137280, a NA study of Schizophrenia and Weight Gain, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,067 participants
- Enrollment target
- 8
- Study locations
Study Summary
This project evaluates the implementation and effectiveness of a care model to improve treatment for schizophrenia within the context of diverse VA practices and priorities. The project provides information to VA clinicians and managers about Veterans with schizophrenia or schizoaffective disorder who are overweight and/or who would like to return to competitive work. The project facilitates reorganization of care practices in order to get veterans needed and desired services around wellness and work. The project creates a platform that other clinical and research interventions can build upon to improve care, and is designed to inform a national strategy for implementing evidence-based care in schizophrenia.
Primary Outcome
The number of participants with one or more weight service appointments in the one year during implementation (implementation sites versus control sites) for those participants who were overweight at the baseline interview (e.g., eligible for weight services). This only includes participants who were overweight at the baseline interview (e.g., eligible for weight services).
Conditions Studied
Interventions
- BEHAVIORAL Collaborative Chronic Illness Care Model
Study Locations (8)
California
- VA Long Beach Healthcare System, Long Beach, CA - Long Beach
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
New York
- Northport VA Medical Center, Northport, NY - Northport
- James J. Peters VA Medical Center, Bronx, NY - The Bronx
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
- Central Texas Veterans Health Care System, Temple, TX - Temple
Louisiana
- Overton Brooks VA Medical Center, Shreveport, LA - Shreveport
Nevada
- VA Southern Nevada Healthcare System, North Las Vegas, NV - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,067 participants |
| Start Date | 2007-06-13 |
| Est. Completion | 2011-05-31 |
| Phase | NA |
What the finished NCT00137280 record still lists
NCT00137280 is an interventional study that assigns participants to a tested intervention. Its 1,067 participants enrollment target places it among the larger protocols in the corpus, above the 216-participant average among 315 other Schizophrenia trials with a reported enrollment target (394% higher).
The record links to 4 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Collaborative Chronic Illness Care Model is the first listed.
NCT00137280 lists 8 locations in 5 states (California, New York, Texas).
Frequently Asked Questions
What is clinical trial NCT00137280 about?
NCT00137280 is a clinical study titled "Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)". This project evaluates the implementation and effectiveness of a care model to improve treatment for schizophrenia within the context of diverse VA practices and priorities. The project provides information to VA clinicians and managers about Veterans with schizophrenia or schizoaffective disorder w...
What is the current status of trial NCT00137280?
This trial is currently completed. It is a NA study. The enrollment target is 1,067 participants. The study started on 2007-06-13. Estimated completion is 2011-05-31.
What conditions does trial NCT00137280 study?
This clinical trial studies the following conditions: Schizophrenia, Weight Gain, Psychotic Disorder, Chronic Illness.
What interventions are being tested in trial NCT00137280?
The interventions under investigation include: Collaborative Chronic Illness Care Model (BEHAVIORAL).
Who is sponsoring clinical trial NCT00137280?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00137280 being conducted?
This trial has 8 study locations across California, Louisiana, Nevada, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00137280's enrollment target sits among peer trials
1,067 8th of 315 higher than 308 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- NCT06751043 · 1,072 participants · NA
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
- NCT06159673 · 1,074 participants · Phase 2
ACP-204 in Adults With Alzheimer's Disease Psychosis
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI